Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Model Immunization Protocols

Oregon licensed immunizing pharmacists must use protocols published by the Oregon Board of Pharmacy

The model immunization protocols (formerly "standing orders") listed below and immunization protocols for any newly recommended vaccines will be updated within one month from the date that ACIP makes its recommendation or at the discretion of the Oregon Health Authority.

An interim protocol is published when clinical guidance is needed but the Advisory Committee on Immunization Practices recommendations haven’t yet been published in the MMWR. The interim protocol will be replaced with a final protocol once the recommendations are published.

Note to clinicians: The vaccines and biologics listed here are routinely recommended in the state of Oregon. Any clinician ordering travel vaccines in addition to these is advised to review package information regarding simultaneous administration.

Model Immunization Protocols

These issues are PDF files that require Adobe Reader software to be read and printed.

Disclaimer of liability, reliability and endorsement.

Vaccine/biologic Date Issued
Guidelines For Managing Adverse Events (Epinephrine)Oct 2023
COVID-19Oct 2023
DTaP, DT and Combination VaccinesAug 2023
Hepatitis A and TwinrixOct 2023
Hepatitis B
Pediatric Formulations
Adult Formulation

Aug 2023
Sep 2022


Hib and combination vaccinesAug 2023
HPV (9vHPV )Aug 2023
Immune globulin, Hepatitis A and MeaslesOct 2023
Immune globulin, Hepatitis BNov 2022
Immune globulin, Tetanus Dec 2022
Immune globulin, VaricellaSep 2023
Influenza (IIV) 2023-24 - InterimJul 2023
Influenza (LAIV) 2023-24 - Interim
Jul 2023
Meningococcal (A, C, Y, W, and B)Aug 2023
MMR and MMRVApr 2023
Pneumococcal VaccinesSep 2023
Polio (inactivated) and combo vaccines Aug 2023
RotavirusDec 2022
RSV monoclonal antibody Oct 2023
RSV VaccineOct 2023
Tdap and Combination Vaccines Tdap ≥7yrs
Nov 2023
TST and Live Virus Vaccines (Optional)Nov 2022
Varicella-containing vaccinesAug 2023
Zoster (Shingrix) Feb 2024 Updated!
Sites For Administration of VaccineNov 2022
Table of ContentsFeb 2024 Updated!

Vaccines for Travelers Date Issued
CholeraDec 2022
Japanese EncephalitisNov 2022
Polio for TravelersDec 2022
RabiesJun 2022
TyphoidDec 2022
Yellow Fever (Optional)Mar 2023

To request this material in an alternative format (e.g. Braille) or to clarify any part of the model immunization protocol, contact the Oregon Health Authority Acute and Communicable Disease Prevention program at 971-673-1111.


Emergency Preparedness / Post-exposure Prophylaxis

The immunization protocol for anthrax includes an additional algorithm. Other post-exposure prophylaxis model immunization protocols will be added as developed and updated.

Emergency Preparedness/
Post-exposure Prophylaxis
Date
Anthrax07/21
COVID-19 Testing
07/22
Meningococcus06/21
MPXV (monkeypox)
03/23
Pertussis10/20
Pneumonic Plague11/21
Smallpox06/21
Tularemia 06/21

Please contact ACDP with any inquiries regarding the above guidelines.

VAERS

Vaccine Adverse Event Reporting

Oregon Public providers are to complete the Vaccine Adverse Events Reporting System (VAERS) report online by going to https://vaers.hhs.gov/reportevent.html. Save the report number for your records.

Private providers are to report adverse events directly to VAERS and can read about options on how to do so at https://vaers.hhs.gov.


Disclaimer of Liability

This site is provided as a public service by the Immunization Program of the Oregon Health Authority Public Health Division. The model immunization protocols provided here are intended for use by the public and private sectors to promote quality standard of practice in immunization. This information is designed to help practitioners provide precise and timely immunization services to the client. These protocols are not in effect unless they have been reviewed and authorized by a medical doctor. Although the information and forms displayed here are carefully reviewed before publication, in providing immunizations, the practitioner should consult the package insert and recommendations made by both the American Academy of Pediatrics and the Advisory Committee on Immunization Practices. The state of Oregon does not make either express or implied warranties regarding the use of these forms and information. Each practitioner must depend on his or her own knowledge and expertise in using or modifying these forms and information.

Disclaimer of Reliability
In preparation of these sites, every effort has been made to offer the most current information possible. The information and data included on this have been compiled by state staff from a variety of sources, and are subject to change without notice. The state of Oregon makes no warranties or representation whatsoever regarding the quality, content, completeness, or adequacy of such information and data. The state of Oregon disclaims any responsibility for typographical errors and accuracy of the information that may be contained on state of Oregon web pages. In any situation where the official printed publications of the state of Oregon differ from the text contained in this system, official printed documents take precedence.

The state of Oregon makes no representations or warranties regarding the condition or functionality of this web site, its suitability for use, or that this web service will be uninterrupted or error-free. If misleading, inaccurate or otherwise inappropriate information is brought to our attention, a reasonable effort will be made to fix or remove it. Such concerns should be addressed to the Immunization Program at 971-673-0300.

Disclaimer of Endorsement
Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, nor its recommendation by the state of Oregon. The views and opinions of authors expressed herein do not state or reflect those of the state of Oregon, and may not be used for advertising or product endorsement purposes.